Grant: Planning and Dissemination Grant - Institute Community Support

The COVID-19 pandemic was a major catalyst for research funding, fruitful collaboration and scientific advancement. Importantly, the lessons learned from years of progress and failures in HIV research contributed greatly to the rapid development of safe and effective mRNA vaccines and offered new hope for the elusive quest for a successful HIV vaccine. Today, Canadian researchers continue to make significant contributions to developing a safe, effective, affordable and globally accessible HIV vaccine. Accordingly, this proposal seeks to contribute to the dissemination, exchange and uptake of HIV vaccine research evidence, bringing together Canadian researchers in the field and others interested from all research disciplines to present their work and engage in knowledge translation activities with their peers, as well as with people from other scientific disciplines, public and private sector representatives.